Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

17 December 2021: Animal Study

Galangin Enhances Anticancer Efficacy of 5-Fluorouracil in Esophageal Cancer Cells and Xenografts Through NLR Family Pyrin Domain Containing 3 (NLRP3) Downregulation

Cong Zhang 1ABF* , Cui-Lian Luo 1BCD* , Guan-Sheng Shang 1DE , De-Xiong Jiang 1BF , Qi Song 2AG*

DOI: 10.12659/MSM.931630

Med Sci Monit 2021; 27:e931630

Figure 1 Effects of 5-fluorouracil (5-FU) and galangin on the proliferation of normal human esophageal cells and malignant cells. Het-1A, Eca109, and OE19 cells were incubated with different concentrations of 5-FU (A), galangin (B), and combined therapy (C) for 48–72 h, and the absorbance by CCK-8 assay was calculated compared with the control group independently. Data are shown as the mean±SEM of 3 independent experiments. * P<0.05 vs control group, ** P<0.01 vs control group for 48 h; # P<0.05 vs control group, ## P<0.01 vs control group for 72 h.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750